Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Matinas BioPharma Holdings, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +3 vs. Q4 2024
- Shares held
- 320.2K
- −49.4K (−13.4%) vs. Q4 2024
- Total value
- $166.5K
- −$27.6K (−14.2%) vs. Q4 2024
- New holders
- 5
- 7 more added
- Sold out
- 2
- 3 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MTNB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $199.2K |
| Q1 2026 | 28 | $177.3K |
| Q4 2025 | 30 | $260.3K |
| Q3 2025 | 28 | $617.7K |
| Q2 2025 | 24 | $254.1K |
| Q1 2025 | 25 | $166.5K |
| Q4 2024 | 22 | $194.1K |
| Q3 2024 | 18 | $1.97M |
| Q2 2024 | 48 | $6.15M |
| Q1 2024 | 42 | $6.91M |
| Q4 2023 | 52 | $5.61M |
| Q3 2023 | 47 | $3.37M |
| Q2 2023 | 51 | $9.31M |
| Q1 2023 | 51 | $12.6M |
| Q4 2022 | 57 | $13.6M |
| Q3 2022 | 55 | $18.0M |
| Q2 2022 | 50 | $21.5M |
| Q1 2022 | 56 | $20.3M |
| Q4 2021 | 66 | $27.4M |
| Q3 2021 | 67 | $33.5M |
| Q2 2021 | 67 | $29.2M |
| Q1 2021 | 80 | $41.7M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Matinas BioPharma Holdings, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 59,725 | $31.1K | 0.00% | −46,769−43.9% | Reduced |
| BlackRock, Inc. | 49,650 | $25.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 46,741 | $24.3K | 0.00% | +3,274+7.5% | Added |
| Sargent Investment Group, LLC | 41,800 | $21.7K | 0.00% | −22,400−34.9% | Reduced |
| Holos Integrated Wealth LLC | 32,480 | $16.9K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 25,610 | $13.3K | 0.00% | +1,808+7.6% | Added |
| Renaissance Technologies LLC | 22,370 | $11.6K | 0.00% | +4,200+23.1% | Added |
| Two Sigma Securities, LLC | 20,974 | $10.9K | 0.00% | +20,974 | New |
| State Street Corp | 15,322 | $7.97K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,640 | $853 | 0.00% | −10,673−86.7% | Reduced |
| Tower Research Capital LLC (TRC) | 1,108 | $576 | 0.00% | +6+0.5% | Added |
| Bank of America Corp | 976 | $507 | 0.00% | +1+0.1% | Added |
| JPMorgan Chase & Co | 904 | $470 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 210 | $108 | 0.00% | +10+5.0% | Added |
| Costello Asset Management, INC | 200 | $104 | 0.00% | +200 | New |
| Morgan Stanley | 144 | $75 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 102 | $53 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 61 | $32 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 60 | $31 | 0.00% | 00.0% | Unchanged |
| Vision Financial Markets LLC | 40 | $21 | 0.00% | +40 | New |
| Rothschild Investment LLC | 14 | $7 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 13 | $7 | 0.00% | +2+18.2% | Added |
| Farther Finance Advisors, LLC | 5 | $3 | 0.00% | +5 | New |
| GWM Advisors LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1 | $1 | 0.00% | +1 | New |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −35−100.0% | Sold out |